Full Paper
128.2, 128.0, 126.2, 115.6 (d, J = 9.3 Hz), 110.9 (d, J = 24.9 Hz), 105.9
Methyl 2-(3-Hydroxy-2-methoxy-1-oxo-1,2,3,4-tetrahydro-
(d, J = 23.9 Hz), 104.2 (d, J = 3.8 Hz), 91.2, 63.6, 38.2 ppm. 19F pyrimido[1,6-a]indol-3-yl)acetate (3ag): White solid (90 %); m.p.
1
NMR (376 MHz, [D6]DMSO): δ = –119.99 ppm. HRMS (ESI): calcd. for
168–170 °C. H NMR (400 MHz, [D6]DMSO): δ = 8.21 (d, J = 7.6 Hz,
1 H), 7.53 (d, J = 7.2 Hz, 1 H), 7.27–7.20 (m, 2 H), 7.00 (s, 1 H), 6.50
(s, 1 H), 3.83 (s, 3 H), 3.66 (d, J = 16.8 Hz, 1 H), 3.62 (s, 3 H), 3.47 (d,
J = 16.4 Hz, 1 H), 3.06 (s, 2 H) ppm. 13C NMR (100 MHz, [D6]DMSO):
δ = 169.3, 151.3, 134.6, 132.1, 129.8, 123.4, 123.0, 120.1, 114.5, 104.5,
87.9, 64.1, 51.6, 41.1, 34.0 ppm. HRMS (ESI): calcd. for [C15H16N2O5
+ Na]+ 327.0951; found 327.0935.
[C18H15FN2O3 + Na]+ 349.0959; found 349.0939.
3-Hydroxy-2,7-dimethoxy-3-phenyl-3,4-dihydropyrimido-
[1,6-a]indol-1(2H)-one (3ga): White solid (66 %); m.p. 206–209 °C.
1H NMR (400 MHz, [D6]DMSO): δ = 8.13 (d, J = 8.8 Hz, 1 H), 7.62 (d,
J = 7.6 Hz, 2 H), 7.43–7.31 (m, 4 H), 7.06 (d, J = 2.4 Hz, 1 H), 6.88
(dd, J = 9.0, J = 2.6 Hz, 1 H), 6.35 (s, 1 H), 3.78 (s, 3 H), 3.72 (d, J =
16.4 Hz, 1 H), 3.61 (s, 3 H), 3.34 (d, J = 16.0 Hz, 1 H) ppm. 13C NMR
3-Hydroxy-2-methoxy-3-(4-nitrophenyl)-3,4-dihydropyr-
(100 MHz, [D6]DMSO): δ = 155.8, 152.3, 141.2, 133.1, 130.9, 129.3, imido[1,6-a]indol-1(2H)-one (3ah): Yellow solid (88 %); m.p. 201–
1
128.1, 127.9, 126.1, 115.1, 111.8, 104.2, 103.2, 91.1, 63.6, 55.3,
38.2 ppm. HRMS (ESI): calcd. for [C19H18N2O4 + Na]+ 361.1159; found
361.1142.
203 °C. H NMR (400 MHz, [D6]DMSO): δ = 8.31–8.26 (m, 3 H), 7.95
(d, J = 8.8 Hz, 2 H), 7.68 (s, 1 H), 7.56 (d, J = 7.2 Hz, 1 H), 7.32–7.22
(m, 2 H), 6.48 (s, 1 H), 3.82 (d, J = 16.0 Hz, 1 H), 3.36 (s, 3 H), 3.40
(d, J = 16.4 Hz, 1 H) ppm. 13C NMR (100 MHz, [D6]DMSO): δ = 152.1,
148.3, 147.3, 134.8, 132.1, 129.9, 127.8, 123.7, 123.23, 123.17, 120.3,
114.6, 104.7, 90.6, 63.7, 37.7 ppm. HRMS (ESI): calcd. for [C18H15N3O5
+ Na]+ 376.0904; found 376.0892.
3-(4-Fluorophenyl)-3-hydroxy-2-methoxy-3,4-dihydropyr-
imido[1,6-a]indol-1(2H)-one (3ab): Yellow solid (76 %); m.p. 184–
1
186 °C. H NMR (400 MHz, [D6]DMSO): δ = 8.31 (d, J = 8.0 Hz, 1 H),
7.72 (dd, J = 8.2, J = 5.4 Hz, 2 H), 7.58 (d, J = 7.2 Hz, 1 H), 7.44 (s, 1
H), 7.34–7.25 (m, 4 H), 6.49 (s, 1 H), 3.81 (d, J = 16.0 Hz, 1 H), 3.66
3-(4-Bromophenyl)-3-hydroxy-2-methoxy-3,4-dihydropyr-
(s, 3 H), 3.41 (d, J = 15.6 Hz, 1 H) ppm. 13C NMR (100 MHz, imido[1,6-a]indol-1(2H)-one (3ai): White solid (86 %); m.p. 206–
1
[D6]DMSO): δ = 161.8 (d, J = 242.9 Hz), 152.3, 137.4 (d, J = 2.9 Hz),
134.8, 132.4, 129.9, 128.5 (d, J = 8.3 Hz), 123.5, 123.1, 120.3, 114.8,
114.6 (d, J = 4.8 Hz), 104.4, 90.6, 63.6, 38.1 ppm. 19F NMR (376 MHz,
207 °C. H NMR (400 MHz, [D6]DMSO): δ = 8.26 (d, J = 8.0 Hz, 1 H),
7.64–7.58 (m, 4 H), 7.54 (d, J = 7.6 Hz, 1 H), 7.43 (s, 1 H), 7.30–7.21
(m, 2 H), 6.45 (s, 1 H), 3.75 (d, J = 16.4 Hz, 1 H), 3.63 (s, 3 H), 3.36
[D6]DMSO): δ = –114.50 ppm. HRMS (ESI): calcd. for [C18H15FN2O3 + (d, J = 16.4 Hz, 1 H) ppm. 13C NMR (100 MHz, [D6]DMSO): δ = 152.2,
Na]+ 349.0959; found 349.0944.
140.6, 134.7, 132.3, 130.9, 129.9, 128.5, 123.5, 123.1, 121.5, 120.3,
114.6, 104.4, 90.7, 63.6, 37.9 ppm. HRMS (ESI): calcd. for
[C18H14BrN2O3]– 385.0193; found 385.0200.
3-(4-Chlorophenyl)-3-hydroxy-2-methoxy-3,4-dihydropyr-
imido[1,6-a]indol-1(2H)-one (3ac): White solid (91 %); m.p. 197–
1
200 °C. H NMR (400 MHz, [D6]DMSO): δ = 8.28 (d, J = 8.0 Hz, 1 H),
3-Hydroxy-2-methoxy-3-(4-methoxyphenyl)-3,4-dihydropyr-
7.67 (d, J = 7.6 Hz, 2 H), 7.56–7.44 (m, 4 H), 7.31–7.24 (m, 2 H), 6.46
(s, 1 H), 3.77 (d, J = 16.0 Hz, 1 H), 3.63 (s, 3 H), 3.37 (d, J = 16.4 Hz,
imido[1,6-a]indol-1(2H)-one (3aj): White solid (66 %); m.p. 188–
1
189 °C. H NMR (400 MHz, [D6]DMSO): δ = 8.26 (d, J = 8.0 Hz, 1 H),
1 H) ppm. 13C NMR (100 MHz, [D6]DMSO): δ = 152.2, 140.2, 134.7, 7.53 (d, J = 7.6 Hz, 3 H), 7.28–7.20 (m, 3 H), 6.95 (d, J = 8.8 Hz, 2 H),
132.8, 132.3, 129.9, 128.2, 128.0, 123.5, 123.1, 120.3, 114.6, 104.4, 6.42 (s, 1 H), 3.76 (s, 3 H), 3.74 (d, J = 14.4 Hz, 1 H), 3.62 (s, 3 H),
90.6, 63.6, 37.9 ppm. HRMS (ESI): calcd. for [C18H15ClN2O3 + Na]+
365.0663; found 365.0646.
3.35 (d, J = 16.8 Hz, 1 H) ppm. 13C NMR (100 MHz, [D6]DMSO): δ =
158.9, 152.3, 134.7, 133.1, 132.6, 129.9, 127.5, 123.4, 123.0, 120.2,
114.5, 113.2, 104.2, 90.8, 63.6, 55.1, 38.2 ppm. HRMS (ESI): calcd. for
[C19H18N2O4 + Na]+ 361.1159; found 361.1142.
3-Hydroxy-2-methoxy-6-methyl-3-phenyl-3,4-dihydropyr-
imido[1,6-a]indol-1(2H)-one (3ad): White solid (88 %); m.p. 204–
1
205 °C. H NMR (400 MHz, [D6]DMSO): δ = 8.26 (d, J = 8.0 Hz, 1 H),
2-Ethoxy-3-hydroxy-3-phenyl-3,4-dihydropyrimido[1,6-a]indol-
1(2H)-one (3ha): White solid (66 %); m.p. 200–203 °C. 1H NMR
(400 MHz, CDCl3): δ = 8.41 (d, J = 8.4 Hz, 1 H), 7.65 (d, J = 7.6 Hz,
2 H), 7.47–7.35 (m, 4 H), 7.32–7.28 (m, 1 H), 7.25–7.21 (m, 1 H), 6.32
7.91 (d, J = 1.6 Hz, 1 H), 7.72–7.64 (m, 2 H), 7.55–7.54 (m, 2 H), 7.31–
7.22 (m, 2 H), 6.47 (s, 1 H), 3.83 (d, J = 16.4 Hz, 1 H), 3.63 (s, 3 H),
3.37 (d, J = 16.4 Hz, 1 H) ppm. 13C NMR (100 MHz, [D6]DMSO): δ =
152.1, 142.3, 134.7, 132.2, 130.9, 130.8, 130.3, 129.9, 128.6, 126.7, (s, 1 H), 4.25–4.17 (m, 2 H), 3.75 (br., 1 H), 3.65 (d, J = 16.4 Hz, 1 H),
123.6, 123.1, 120.3, 114.6, 104.6, 90.2, 63.7, 37.6 ppm. HRMS (ESI):
3.47 (d, J = 16.4 Hz, 1 H), 0.83 (t, J = 6.8 Hz, 3 H) ppm. 13C NMR
(100 MHz, [D6]DMSO): δ = 152.4, 141.1, 134.8, 132.6, 129.9, 128.1,
127.9, 126.2, 123.4, 123.0, 120.2, 114.5, 104.2, 90.8, 71.7, 37.9,
13.3 ppm. HRMS (ESI): calcd. for [C19H18N2O3 + Na]+ 345.1210; found
345.1192.
calcd. for [C18H14Cl2N2O3 + Na]+ 399.0274; found 399.0258.
3-Hydroxy-2-methoxy-3-(p-tolyl)-3,4-dihydropyrimido[1,6-a]-
indol-1(2H)-one (3ae): White solid (87 %); m.p. 198–201 °C. 1H NMR
(400 MHz, [D6]DMSO): δ = 8.27 (d, J = 8.0 Hz, 1 H), 7.53–7.49 (m, 3
H), 7.29–7.19 (m, 5 H), 6.42 (s, 1 H), 3.72 (d, J = 16.0 Hz, 1 H), 3.63
Dehydration Reaction of Dihydropyrimido[1,6-a]indolone De-
(s, 3 H), 3.34 (d, J = 16.0 Hz, 1 H), 2.31 (s, 3 H) ppm. 13C NMR rivatives 3aa for the Synthesis of Pyrimido[1,6-a]indolone 4aa:
(100 MHz, [D6]DMSO): δ = 152.4, 138.3, 137.3, 134.8, 132.5, 129.9, A mixture of N-carbamoylindole 3aa (0.10 mmol) and anhydrous
128.5, 126.1, 123.4, 123.0, 120.2, 114.5, 104.2, 91.0, 63.6, 38.2,
20.6 ppm. HRMS (ESI): calcd. for [C19H18N2O3 + Na]+ 345.1210; found
345.1215.
AlCl3 (0.20 mmol) in MeOH (1 mL) was stirred at room temperature
for 2 h. Then, the mixture was concentrated. The residue was sub-
jected to flash column chromatography [silica gel; ethyl acetate/
petroleum ether (1:10, v/v)] to give pyrimido[1,6-a]indolone 4aa.
3-(tert-Butyl)-3-hydroxy-2-methoxy-3,4-dihydropyrimido-
[1,6-a]indol-1(2H)-one (3af): White solid (63 %); m.p. 151–153 °C.
1H NMR (400 MHz,[D6]DMSO): δ = 8.20 (d, J = 7.6 Hz, 1 H), 7.51 (d,
J = 6.8 Hz, 1 H), 7.22–7.18 (m, 2 H), 6.43 (s, 1 H), 6.39 (s, 1 H), 3.86
(s, 3 H), 3.63 (d, J = 16.4 Hz, 1 H), 3.28 (d, J = 17.2 Hz, 1 H), 0.92 (s,
2-Methoxy-3-phenylpyrimido[1,6-a]indol-1(2H)-one (4aa): Yel-
low solid (77 %); a melting point could not be obtained due to the
thermal instability of the compound. 1H NMR (400 MHz, CDCl3): δ =
8.69–8.65 (m, 1 H), 7.66–7.62 (m, 3 H), 7.48–7.46 (m, 3 H), 7.40–7.36
9 H) ppm. 13C NMR (100 MHz, [D6]DMSO): δ = 149.5, 134.6, 132.6, (m, 2 H), 6.57 (s, 1 H), 6.38 (s, 1 H), 3.70 (s, 3 H) ppm. 13C NMR
129.6, 123.2, 122.7, 120.1, 114.2, 102.7, 93.6, 64.3, 40.6, 33.2,
26.0 ppm. HRMS (ESI): calcd. for [C16H20N2O3 + Na]+ 311.1366; found
311.1344.
(100 MHz, CDCl3): δ = 146.5, 139.0, 133.8, 133.7, 132.0, 130.9, 129.5,
129.1, 128.5, 124.2, 123.1, 120.1, 116.1, 99.2, 99.1, 63.9 ppm. HRMS
(EI-TOF): calcd. for C18H14N2O2 [M]+ 290.1055; found 290.1057.
Eur. J. Org. Chem. 0000, 0–0
5
© 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim